Patents Assigned to Altana Pharma, AG
  • Publication number: 20070272236
    Abstract: The present invention relates to a cap (1) which is placed onto an aerosol container (2) in order to permit blinding of clinical studies.
    Type: Application
    Filed: May 2, 2005
    Publication date: November 29, 2007
    Applicant: ALTANA PHARMA AG
    Inventor: Jutta Pfeiffer
  • Publication number: 20070270441
    Abstract: The invention relates to the combined administration of a PDE4 or PDE3/4 inhibitor and a disease modifying anti-rheumatic drug (DMARDs) or anti-rheumatic or anti-arthritic drug.
    Type: Application
    Filed: July 19, 2007
    Publication date: November 22, 2007
    Applicant: Altana Pharma AG
    Inventor: Johannes Barsig
  • Publication number: 20070259909
    Abstract: Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
    Type: Application
    Filed: March 8, 2005
    Publication date: November 8, 2007
    Applicant: ALTANA PHARMA AG
    Inventor: Ulrich Kautz
  • Publication number: 20070259009
    Abstract: An aqueous pharmaceutical preparation for administration of a slightly soluble PDE4 inhibitor is described.
    Type: Application
    Filed: September 21, 2005
    Publication date: November 8, 2007
    Applicant: Altana Pharma AG
    Inventor: Rudolf Linder
  • Publication number: 20070259868
    Abstract: The compounds of formula I in which R1, R2 and R3 have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: September 5, 2005
    Publication date: November 8, 2007
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Ulrich Kautz, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Jens Christoffers, Anna Rosiak
  • Publication number: 20070254046
    Abstract: Compounds of a certain formula I in which R1, R2, R3 and R4 have the meanings indicated in the description are novel compounds expected to be useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis.
    Type: Application
    Filed: September 5, 2005
    Publication date: November 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Thomas Maier, Armin Zuelch, Thomas Ciossek, Thomas Baer, Thomas Beckers
  • Publication number: 20070254928
    Abstract: The invention relates to the use of roflumilast for the prophylaxis of or the treatment of emphysema.
    Type: Application
    Filed: May 4, 2005
    Publication date: November 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Stefan-Lutz Wollin, Rolf Beume, Giuseppe Lungarella, Piero Martorana
  • Publication number: 20070244173
    Abstract: The invention provides compounds of the formula 1, in which the substituents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Application
    Filed: October 18, 2006
    Publication date: October 18, 2007
    Applicant: Altana Pharma AG
    Inventor: Wilm Buhr
  • Publication number: 20070244154
    Abstract: The invention relates to compounds of the formula (1) in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 18, 2007
    Applicant: Altana Pharma AG
    Inventor: Christof Brehm
  • Publication number: 20070244112
    Abstract: Compounds of a certain formula (I) in which Ra and Rb have the meanings indicated in the description, are novel, effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: May 25, 2005
    Publication date: October 18, 2007
    Applicant: Altana Pharma AG
    Inventors: Klaus Pekari, Thomas Baer, Bjorn Bartels, Mathias Schmidt, Thomas Beckers
  • Publication number: 20070232596
    Abstract: Compounds of the formula (1) in which R1, R2, R3, R4 and X have the meanings indicated in the description, are novel effective compounds with Eg5 inhibitory, anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: August 17, 2005
    Publication date: October 4, 2007
    Applicant: Altana Pharma AG
    Inventors: Matthias Vennemann, Thomas Baer, Gudrun Groegor, Jurgen Braunger, Petra Gimmnich, Thomas Maier, Heike Rothfels
  • Publication number: 20070225500
    Abstract: The invention relates to a novel process for preparing mixtures of enantiomers of PPI's having a sulphinyl structure using a mixture of enantiomers of chiral zirconium complexes or chiral hafnium complexes.
    Type: Application
    Filed: May 31, 2005
    Publication date: September 27, 2007
    Applicant: Altana Pharma AG
    Inventors: Bernhard Kohl, Bernd Mueller, Ralf Weingart
  • Publication number: 20070208051
    Abstract: Compounds of the formula I in which the substitutents have the definitions provided in the specification, are novel, effective PDE 3/4 inhibitors.
    Type: Application
    Filed: March 16, 2005
    Publication date: September 6, 2007
    Applicant: Altana Pharma AG
    Inventor: Dieter Flokerzi
  • Publication number: 20070191414
    Abstract: Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
    Type: Application
    Filed: March 8, 2005
    Publication date: August 16, 2007
    Applicant: Altana Pharma AG
    Inventor: Ulrich Kautz
  • Publication number: 20070191334
    Abstract: The invention provides compounds of the formula I in which the substitutents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Application
    Filed: March 16, 2005
    Publication date: August 16, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Andreas Palmer, Wilm Buhr
  • Patent number: 7256293
    Abstract: The invention relates to compounds of the formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceutical active compounds.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: August 14, 2007
    Assignee: Altana Pharma AG
    Inventors: Christof Brehm, Wilm Buhr
  • Publication number: 20070185067
    Abstract: The invention relates to pharmaceutical formulations containing combinations of ciclesonide and a pharmaceutically acceptable salt of glycopyrronium and the use of such pharmaceutical compositions in medicine, in particular in the prophylaxis and treatment of respiratory disease.
    Type: Application
    Filed: February 25, 2005
    Publication date: August 9, 2007
    Applicant: Altana Pharma AG
    Inventors: Rene Roscher, Christoph Karl
  • Publication number: 20070184979
    Abstract: Compounds of the formula I in which the substitutents have the definitions provided in the specification, are novel, effective HDAC inhibitors.
    Type: Application
    Filed: March 10, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Thomas Maier, Thomas Beckers, Thomas Baer, Petra Gimmnich, Frank Dullweber, Matthias Vennemann
  • Publication number: 20070185114
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: March 3, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Publication number: 20070185149
    Abstract: Compounds of the formula I in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
    Type: Application
    Filed: March 9, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventor: Ulrich Kautz